NorthWest Biotherapeutics Inc (NWBO)

[ou71764]

Flipper, even though 15 patients per quarter sounds low given what we know about the vaccine now, I suspect that initial enrollment was less than that for the first few quarters.

I don't have enough data to guess what the stats were in December. I think it's likely that the data was very good but hadn't reached statistical significance yet.

If the data is coming in as good as I hope, and the only reason we get the "continue" instead of the "halt" is because there weren't enough patients yet, then a halt at the 2nd interim analysis becomes far more likely.

I wish we could see the data and not just get the DMC's recommendation.